Circulatory support with Impella CP device during high-risk percutaneous coronary interventions: initial experience in Poland
نویسندگان
چکیده
Corresponding author: Dariusz Dudek MD, PhD, Department of Interventional Cardiology, Jagiellonian University Medical College, Institute of Cardiology, 17 Kopernika St, 31-501 Krakow, Poland, phone: +48 12 424 71 81, fax: +48 12 424 71 84, e-mail: [email protected] Received: 1.03.2016, accepted: 14.06.2016. Circulatory support with Impella CP device during high-risk percutaneous coronary interventions: initial experience in Poland
منابع مشابه
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
OBJECTIVES We sought to evaluate the safety and feasibility of the Impella 2.5 system (Abiomed Inc., Danvers, Massachusetts) in patients undergoing high-risk percutaneous coronary intervention (PCI). BACKGROUND The Impella 2.5 is a miniaturized percutaneous cardiac assist device, which provides up to 2.5 l/min forward flow from the left ventricle into the systemic circulation. METHODS In a ...
متن کاملAvoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
The rate of performing primary percutaneous coronary intervention in patients with complex coronary artery disease is increasing. The use of percutaneous mechanical circulatory support devices provides critical periprocedural hemodynamic support. Mechanical support has increased the safety and efficacy of interventional procedures in this high-risk patient population. Predicting patient respons...
متن کاملThe Duration of Impella 2.5 Circulatory Support and Length of Hospital Stay of Patients Undergoing High-risk Percutaneous Coronary Interventions
BACKGROUND To evaluate the impact of duration of Impella 2.5 support (Abiomed, Danvers, MA) on hospitalization of patients after high-risk percutaneous coronary intervention (PCI). There has been a continuous increase in prevalence of coronary artery disease with more patients needing PCI during acute myocardial infarction. Some of these patients have to undergo high-risk revascularization with...
متن کاملHigh-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation
Corresponding author: Adam Sukiennik MD, PhD, Department of Cardiology and Internal Diseases, University Hospital No. 1, Collegium Medicum, Nicolaus Copernicus University, 9 M. Skłodowskiej-Curie St, 85-094 Bydgoszcz, Poland, phone: +48 52 585 40 23, fax: +48 52 585 40 24, e-mail: [email protected] Received: 10.02.2016, accepted: 6.09.2016. High-risk percutaneous coronary intervention with Im...
متن کاملInitial experience with the Impella Recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty.
INTRODUCTION The Impella LP 2.5 device is a new percutaneous left ventricular assist device, an intravascular micro-axial blood pump designed for short term circulatory support in conditions characterized by profoundly reduced ventricular function. Percutaneous coronary intervention (PCI) is increasingly being used in patients who have severely compromised left ventricular contractility and com...
متن کامل